Parlodel
Parlodel contains bromocriptine mesylate, an ergot derivative that acts as a dopamine receptor agonist. It decreases the secretion of prolactin from the pituitary gland and stimulates dopamine receptors in the brain to help manage motor symptoms in Parkinson's disease.
Dosage by Body Weight
Dosage must be individualized and titrated slowly to minimize side effects. Typically started at a low dose of 1.25 mg to 2.5 mg daily, taken with food. Always follow specific medical supervision for dose escalation.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in infants.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in this pediatric range.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in this pediatric range.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in young children.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established. Pediatric use is generally restricted to patients aged 11 years and older under specialist guidance.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established in infants. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy have not been established in this pediatric range. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy have not been established in this pediatric range. |
| 11-15 kg | Not recommended | N/A | Safety and efficacy have not been established in young children. |
| 16-20 kg | Not recommended | N/A | Safety and efficacy have not been established. Pediatric use is generally restricted to patients aged 11 years and older under specialist guidance. |
Formulation
Purpose
Treatment of hyperprolactinemia-associated conditions including amenorrhea, female infertility, and galactorrhea; acromegaly; prolactin-secreting adenomas; and Parkinson's disease.
Generic Name
BromocriptineScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.